Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

TAT 2015: Cutting edge research and unique interaction between academia and industry

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
TAT 2015: Cutting edge research and unique interaction between academia and industry ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )
14 Oct 2014

Meeting highlights from the 12th iwNHL 2014: Day 1

Prof John Gribben; Dr Myron Czuczman; Dr Randy Gascoyne; Dr Wyndham Wilson
Meeting highlights from the 12th iwNHL 2014: Day 1 ( Prof John Gribben; Dr Myron Czuczman; Dr Randy Gascoyne; Dr Wyndham Wilson )
8 Oct 2014

Meeting highlights from the 12th iwNHL 2014: Day 2

Prof John Gribben; Dr Myron Czuczman; Dr Wyndham Wilson; Prof Anton Hagenbeek; Professor Michael Pfreundschuh
Meeting highlights from the 12th iwNHL 2014: Day 2 ( Prof John Gribben; Dr Myron Czuczman; Dr Wyndham Wilson; Prof Anton Hagenbeek; Professor Michael Pfreundschuh )
8 Oct 2014

ESMO 2014 Editor's roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ESMO 2014 Editor's roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
8 Oct 2014

Prognostic biomarkers will detect lung cancer at earlier stages

Prof Giulia Veronesi - European Institute of Oncology, Milan, Italy
Prognostic biomarkers will detect lung cancer at earlier stages ( Prof Giulia Veronesi - European Institute of Oncology, Milan, Italy )
2 Oct 2014

vandetanib improves PFS in thyroid cancer

Dr Enrique Grande - Hospital Universitario Ramón y Cajal, Madrid, Spain
vandetanib improves PFS in thyroid cancer ( Dr Enrique Grande - Hospital Universitario Ramón y Cajal, Madrid, Spain )
2 Oct 2014

E-hospital: Fully coordinated cancer care and research in Europe

Prof Alexander Eggermont - Gustave Roussy, Villejuif, France
E-hospital: Fully coordinated cancer care and research in Europe ( Prof Alexander Eggermont - Gustave Roussy, Villejuif, France )
2 Oct 2014

ESMO Highlights: Breast cancer

Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
ESMO Highlights: Breast cancer ( Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
2 Oct 2014

Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma

Dr Caroline Robert - Gustave Roussy, Villejuif, France
Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma ( Dr Caroline Robert - Gustave Roussy, Villejuif, France )
29 Sep 2014

Nivolumab potentially superior to standard chemo in advanced melanoma

Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab potentially superior to standard chemo in advanced melanoma ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
29 Sep 2014

Targeted therapy for iodine-refractory thyroid cancer

Dr Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan
Targeted therapy for iodine-refractory thyroid cancer ( Dr Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan )
29 Sep 2014

Young oncologists bridging the gap between translational and clinical cancer research

Prof Joan Seoane - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Young oncologists bridging the gap between translational and clinical cancer research ( Prof Joan Seoane - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
29 Sep 2014